Currently submitted to: JMIR Research Protocols
Date Submitted: Jan 27, 2026
Open Peer Review Period: Jan 28, 2026 - Mar 25, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Pneumococcal vaccination uptake in people with immunosuppressed conditions using real-world primary care data across England: Protocol for a retrospective descriptive study
ABSTRACT
Background:
The introduction of pneumococcal vaccination programmes in the UK has led to substantial reduction in the burden of pneumococcal disease in the general population, decreasing the incidence of invasive pneumococcal disease (IPD) and preventing associated mortality.
Objective:
We aim to evaluate the yearly uptake of pneumococcal vaccine in adults who are included in national recommendations as people with immunosuppressive conditions, stratified by aetiology of immunosuppression.
Methods:
This will be a retrospective cohort study with data from the Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) network, which is nationally representative of the English population. The population are adults registered in the RSC database with immunosuppression, including those with bone marrow compromise, solid organ transplant, receiving oncological treatment, using immunosuppressive drugs, or with primary or acquired immunodeficiencies. The exposure is the underlying medical condition leading to an immunosuppression category. The primary outcome will be pneumococcal vaccination, defined as one dose of PPV23. Vaccination rates will be calculated using the number of vaccinated people in high-risk groups as the numerator and estimates of the total high-risk population in the RSC dataset as the denominator. We will compare amongst vaccinated and unvaccinated people, and across immunosuppressive aetiologies using descriptive statistics, with pairwise comparisons using standardized mean differences.
Results:
We will report pneumococcal vaccine uptake disaggregated for the high-risk group of people with immunosuppressive conditions, which have not been previously reported. We will report on the socioeconomic gradient for vaccine uptake, through the use of the index of multiple deprivation score and region; report on the differences amongst ethnic groups; and report on vaccination uptake during the COVID-19 pandemic period. We will curate an ontology for immunosuppressive conditions, contributing to CMR research following the open science frameworks for reproducible research.
Conclusions:
We will inform on the granularity of routine primary care data to include disaggregated reports of vaccine uptake in the immunosuppressed population in routine surveillance in the UK. This will aim to address the gap on pneumococcal vaccination coverage in people with immunosuppressive conditions, helping to identify potential unwarranted variations in vaccine adoption.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.